Discovery of natural‐derived Mpro inhibitors as therapeutic candidates for COVID‐19: Structure‐based pharmacophore screening combined with QSAR analysis
Authors:
- 10 February 2023
- journal article
- research article
- Published by Wiley in Molecular Informatics
- Vol. 42 (4) , e2200198
Abstract
The main protease (Mpro) is an essential enzyme for the life cycle of SARS‐CoV‐2 and a validated target for treatment of COVID‐19 infection. Structure‐based pharmacophore modeling combined with QSAR calculations were employed to identify new chemical scaffolds of Mpro inhibitors from natural products repository. Hundreds of pharmacophore models were manually built from their corresponding X‐ray crystallographic structures. A pharmacophore model that was validated by receiver operating characteristic (ROC) curve analysis and selected using the statistically optimum QSAR equation was implemented as a 3D‐search tool to mine AnalytiCon Discovery database of natural products. Captured hits that showed the highest predicted inhibitory activities were bioassayed. Three active Mpro inhibitors (pseurotin A, lactupicrin, and alpinetin) were successfully identified with IC50 values in low micromolar range.Keywords
This publication has 37 references indexed in Scilit:
- Antiviral Constituents against Respiratory Viruses from Mikania micranthaJournal of Natural Products, 2009
- Chemical Modification of Pseurotin A: One-pot Synthesis of Synerazol and Pseurotin E and Determination of Absolute Stereochemistry of Pseurotin EThe Journal of Antibiotics, 2008
- Ligand configurational entropy and protein bindingProceedings of the National Academy of Sciences, 2007
- Interpreting Steep Dose-Response Curves in Early Inhibitor DiscoveryJournal of Medicinal Chemistry, 2006
- Analgesic and sedative activities of lactucin and some lactucin-like guaianolides in miceJournal of Ethnopharmacology, 2006
- Virtual Screening Workflow Development Guided by the “Receiver Operating Characteristic” Curve Approach. Application to High-Throughput Docking on Metabotropic Glutamate Receptor Subtype 4Journal of Medicinal Chemistry, 2005
- Inhibitory effects of compounds from Zingiberaceae species on platelet activating factor receptor bindingPhytotherapy Research, 2004
- Sesquiterpene Lactones in Tissue Culture ofLactuca virosaPlanta Medica, 1994
- Pseurotin A and 8-O-Demethylpseurotin A fromAspergillus fumigatusand Their Inhibitory Activities on Chitin SynthaseBioscience, Biotechnology, and Biochemistry, 1993
- Database algorithm for generating protein backbone and side-chain co-ordinates from a Cα traceJournal of Molecular Biology, 1991